Heitor Leocádio de Souza Rodrigues

Mr. Heitor Leocádio de Souza Rodrigues

Patologia, Reprodução e Saúde Única, Unesp, Jaboticabal, Brazil
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Cesar Augusto Roque-BordaCesar Augusto Roque-Borda
Cesar Augusto Roque-Borda
Subham Kumar VishwakarmaSubham Kumar Vishwakarma
Subham Kumar Vishwakarma
Oswaldo Julio RamirezOswaldo Julio Ramirez
Oswaldo Julio Ramirez
Heitor Leocádio de Souza RodriguesHeitor Leocádio de Souza Rodrigues
Heitor Leocádio de Souza Rodrigues
LPLaura Maria Duran Gleriani Primo
Laura Maria Duran Gleriani Primo
Fernando Rogério PavanFernando Rogério Pavan
Fernando Rogério Pavan
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains one of the most devastating infectious diseases worldwide, with rising multidrug resistance limiting the effectiveness of conventional treatments. Novel therapeutic approaches are urgently needed to complement or replace existing regimens. Among emerging candidates, antimicrobial peptides (AMPs) stand out as versatile molecules capable of exerting direct antimycobacterial effects while also modulating the host immune response. This review explores peptide-based strategies against TB, with a focus on four major axes of innovation. First, we examine host-directed pathways, including the vitamin D–cathelicidin axis and other immunomodulatory mechanisms and their regulatory role in the induction of endogenous AMPs such as cathelicidin LL-37, which contributes to host-directed defense. Second, we discuss peptide-based vaccines designed to elicit robust and durable protective immunity, representing a complementary alternative to classical vaccine approaches. Third, we highlight the synergistic potential of AMPs in combination with first-line and second-line anti-TB drugs, aiming to restore or enhance bactericidal activity against resistant strains. Finally, we analyze technological platforms, including nanocarriers and inhalable formulations, that enable targeted pulmonary delivery, improve peptide stability, and enhance bioavailability. By integrating molecular design, immune modulation, and advanced delivery systems, peptide-based strategies provide a multifaceted approach to overcoming the limitations of current TB therapy. Collectively, these advances position AMPs not only as promising standalone agents but also as key components in combination and host-directed therapies, with strong potential to reshape the future clinical management of tuberculosis.

25 January 2025 in The Microbe
Verified
Journal Article
Open access
Heitor Leocádio de Souza RodriguesHeitor Leocádio de Souza Rodrigues
Heitor Leocádio de Souza Rodrigues
IKIsis Mari Miyashiro Kolososki
Isis Mari Miyashiro Kolososki
VBValdinete Pereira Benevides
Valdinete Pereira Benevides
Mauro SaraivaMauro Saraiva
Mauro Saraiva
AJAngelo Berchieri Junior
Angelo Berchieri Junior

29 May 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
Heitor Leocádio de Souza RodriguesHeitor Leocádio de Souza Rodrigues
Heitor Leocádio de Souza Rodrigues
VBValdinete Pereira Benevides
Valdinete Pereira Benevides
IKIsis Mari MIyashiro Kolososki
Isis Mari MIyashiro Kolososki
Mauro SaraivaMauro Saraiva
Mauro Saraiva
NSNayla Pádua Del Bianco Gontijo Souki
Nayla Pádua Del Bianco Gontijo Souki
AJAngelo Berchieri Junior
Angelo Berchieri Junior
Background/Objectives: Salmonella enterica subsp. enterica serovar Enteritidis (S. Enteritidis) is a major pathogen associated with poultry products, and the rise of antimicrobial-resistant strains has intensified the need for effective natural control strategies. Essential oils (EOs) are recognized for their antimicrobial potential, but their volatility, instability, and risk of toxicity at high concentrations limit their practical application. Therefore, the objective of this study was to evaluate the antimicrobial efficacy of EOs in broilers infected with S. Enteritidis and to characterize potential synergistic or antagonistic interactions between the oils. Methods: To achieve this, the oils were first assessed through Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC), and Fractional Inhibitory Concentration (FIC) assays, and the most effective ones against S. Enteritidis were selected. These selected oils were then microencapsulated and incorporated into the broiler feed for the in vivo assay. Results: The encapsulated formulation retained key bioactive compounds and significantly reduced bacterial shedding and intestinal colonization when administered to broilers experimentally infected with S. Enteritidis. Broilers receiving the optimized half-dose supplementation exhibited a 36% reduction in fecal shedding and a 4 log10 decrease in cecal bacterial counts compared to untreated controls. A transient reduction in liver colonization was also observed, while feed intake remained unaffected. Conclusions: These findings demonstrate that microencapsulated EOs can serve as an effective natural strategy to control S. Enteritidis in poultry. The results support the broader application of lipid-based encapsulation technologies for improving the functional performance of phytobiotics in animal production.

9 July 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
Mauro SaraivaMauro Saraiva
Mauro Saraiva
Heitor Leocádio de Souza RodriguesHeitor Leocádio de Souza Rodrigues
Heitor Leocádio de Souza Rodrigues
VBValdinete Pereira Benevides
Valdinete Pereira Benevides
CLCandice Maria Cardoso Gomes de Leon
Candice Maria Cardoso Gomes de Leon
SSSilvana Cristina Santos
Silvana Cristina Santos
COCelso Oliveira
Celso Oliveira
Staphylococcus aureus (S. aureus) is a major cause of opportunistic infections in humans and animals, leading to severe systemic diseases. The rise of MDR strains associated with animal carriage poses significant health challenges, underscoring the need to investigate animal-derived S. aureus. Objectives: This study examined the genotypic relatedness and phenotypic profiles of antimicrobial resistance in S. aureus, previously sampled from nostril swabs of healthy horses from two geographically distant Brazilian states (Northeast and South), separated by over 3700 km. The study also sought to confirm the presence of methicillin-resistant (MRSA) and borderline oxacillin-resistant (BORSA) strains and to characterize the isolates through molecular typing using PCR. Methods: Among 123 screened staphylococci, 21 isolates were confirmed as S. aureus via biochemical tests and PCR targeting species-specific genes (femA, nuc, coa). Results: REP-PCR analysis generated genotypic profiles, revealing four antimicrobial resistance patterns, with MDR observed in ten isolates. Six isolates exhibited cefoxitin resistance, suggesting methicillin resistance, despite the absence of the mecA gene. REP-PCR demonstrated high discriminatory power, grouping the isolates into five major clusters. Conclusions: The genotyping indicated no clustering by geographical origin, highlighting significant genetic diversity among S. aureus strains colonizing horses’ nostrils in Brazil. These findings highlight the widespread and varied nature of S. aureus among horses, contributing to a deeper understanding of its epidemiology and resistance profiles in animals across diverse regions. Ultimately, this genetic diversity can pose a public health risk that the epidemiological surveillance services must investigate.

7 August 2024 in Veterinary Radiology & Ultrasound
Verified
Journal Article
Closed access
Heitor Leocádio de Souza RodriguesHeitor Leocádio de Souza Rodrigues
Heitor Leocádio de Souza Rodrigues
LPLaís Elena Oliveira Pimenta
Laís Elena Oliveira Pimenta
LVLídia Maria Amaro Vasconcellos
Lídia Maria Amaro Vasconcellos
MCMárcio Machado Costa
Márcio Machado Costa
LCLeandro Zuccolotto Crivellenti
Leandro Zuccolotto Crivellenti
VMVanessa Martins Fayad Milken
Vanessa Martins Fayad Milken

24 February 2023 in VETERINÁRIA NOTÍCIAS
Verified
Journal Article
Closed access
Heitor Leocádio de Souza RodriguesHeitor Leocádio de Souza Rodrigues
Heitor Leocádio de Souza Rodrigues
VOVinícius José de Oliveira
Vinícius José de Oliveira
Birds belonging to the Psittaciformes order have a wide distribution worldwide, emphasizing the Brazilian biomes, and arecharacterized by their colors and shapes. Due to their vast diversity, these wild animals are targets for traffi cking and illegalcon fi nement in captivity. The stress and self-mutilation of capture are one of the main clinical signs these animals show, leavingthem immunologically vulnerable to infections. Thus, endoparasite infections caused by zoonotic parasites are recurrent in thisgroup of birds. Therefore, this study aimed to evaluate the most recurrent parasitic infections that affect the Psittacidae familyof wild birds, highlighting the relationship between parasitic zoonoses and the concept of One Health. The work consisted ofa literature review of articles related to the incidence of parasites in wild Psittacidae published from 2010, the data the till whenextracted and computed in table form. The most prevalent diseases in the study were capillariasis, ascariasis, eimeriosis, cryptosporidiosis, strongyloidiasis, and giardiasis, and three of the six diseases cited to have the potential for transmissibility between animals and humans. Thus, the measures of approach to these zoonotic diseases are of interest to One Health, making it necessary for the joint action of veterinarians and other health professionals.